What’s Ahead for ACURA PHARMACEUTICALS INC (OTCMKTS:ACUR) After Less Shorted Shares?

June 16, 2018 - By Adrian Erickson

The stock of ACURA PHARMACEUTICALS INC (OTCMKTS:ACUR) registered a decrease of 2.87% in short interest. ACUR’s total short interest was 20,300 shares in June as published by FINRA. Its down 2.87% from 20,900 shares, reported previously. With 17,800 shares average volume, it will take short sellers 1 days to cover their ACUR’s short positions. The short interest to ACURA PHARMACEUTICALS INC’s float is 0.28%.

The stock increased 4.74% or $0.0185 during the last trading session, reaching $0.4085. About 5,993 shares traded. Acura Pharmaceuticals, Inc. (OTCMKTS:ACUR) has 0.00% since June 16, 2017 and is . It has underperformed by 12.57% the S&P500.

Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of products to address medication abuse and misuse. The company has market cap of $8.59 million. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. It currently has negative earnings. The firm has six additional opioid products in various stages of formulation development.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: